Literature DB >> 18231868

Estimating decreased risks for Huntington disease without a test.

Reinier Timman1, Benno Bonke, Theo Stijnen, Aad Tibben, Anneke Maat-Kievit.   

Abstract

The majority of individuals at risk for Huntington disease (HD) is afraid to learn more precisely about their genetic status, as is suggested by the low uptake of the predictive test for HD. Subsequently, the future expectancies of individuals at risk are often based on rough risk estimates such as 50% (child of an affected individual) or 25% (grandchild). Individuals at risk can be offered a better risk estimate based on their current age, length of the disease causing CAG-repeat in the HD gene in close relatives, information on the age at onset, or test results of children. Regression modelling and Cox regression determined relations between ages at onset and CAG repeat length in a sample of 755 tested individuals. A model for calculating the adjusted residual risk status was constructed and implemented in a spreadsheet that can be used in genetic counselling. This model and accompanying spreadsheet broadens the information repertoire for genetic counsellors by providing an optimal estimation of the residual risk status.

Entities:  

Mesh:

Year:  2008        PMID: 18231868     DOI: 10.1007/s10654-008-9224-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Predictability of age at onset in Huntington disease in the Dutch population.

Authors:  Anneke Maat-Kievit; Minique Losekoot; Koos Zwinderman; Maria Vegter-van der Vlis; René Belfroid; Fatima Lopez; Gert-Jan Van Ommen; Martijn Breuning; Raymund Roos
Journal:  Medicine (Baltimore)       Date:  2002-07       Impact factor: 1.889

2.  Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study.

Authors:  Marie-Noëlle W Witjes-Ané; Maria Vegter-van der Vlis; Jeroen P P van Vugt; Jan B K Lanser; Jo Hermans; Aeilko H Zwinderman; Gert-Jan B van Ommen; Raymund A C Roos
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

3.  Age at onset and life table risks in genetic counselling for Huntington's disease.

Authors:  P S Harper; R G Newcombe
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

4.  Genetic testing and Huntington's disease: issues of employment.

Authors:  Peter S Harper; Sjef Gevers; Guido de Wert; Susan Creighton; Yvonne Bombard; Michael R Hayden
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

5.  Covariate-dependent age-at-onset distributions for Huntington disease.

Authors:  M Krawczak; B Bockel; L Sandkuijl; U Thies; I Fenton; P S Harper
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

6.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

7.  Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing.

Authors:  E McCusker; F Richards; D Sillence; M Wilson; R J Trent
Journal:  J Clin Neurosci       Date:  2000-01       Impact factor: 1.961

8.  Reluctance to undergo predictive testing: the case of Huntington disease.

Authors:  K A Quaid; M Morris
Journal:  Am J Med Genet       Date:  1993-01-01

9.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

10.  Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relatives.

Authors:  Benno Bonke; Aad Tibben; Dick Lindhout; Theo Stijnen
Journal:  Hum Genet       Date:  2002-07-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.